Latest Breaking News On - Mark lebwohl - Page 1 : comparemela.com

Choosing the Right Psoriasis Treatment: Tailoring Therapy to Patient Characteristics

Experts discuss the plethora of treatment options for psoriasis, including topicals, oral therapies, phototherapy, and biologics.

Mark Lebwohl, MD: Implications of 4 Year Data on Bimekizumab for Psoriasis Treatment

Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control

Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.

Dr James Q. Del Rosso Explores the Latest Advancements in Dermatology

There are many drugs that have been around for years and others with strong data awaiting FDA approval that are beneficial in treating conditions like atopic dermatitis and alopecia areata, said James Q. Del Rosso, DO.

Deucravacitinib Demonstrates Significantly Greater PASI Reductions in Plaque Psoriasis

Results from the POETYK PSO-1 trial showed significantly greater improvements in patients receiving deucravacitinib compared with placebo or apremilast.